Spironolactone for Hypertension Management
Spironolactone is an effective medication for hypertension, particularly as add-on therapy for resistant hypertension, with strong evidence supporting its use as a fourth-line agent when blood pressure remains uncontrolled on three medications including a diuretic. 1
Indications for Spironolactone in Hypertension
Spironolactone is FDA-approved for the treatment of hypertension as add-on therapy to lower blood pressure in patients not adequately controlled on other agents 2. Its use in hypertension management can be categorized as follows:
As Standard Antihypertensive Therapy
- Classified as a potassium-sparing diuretic in hypertension guidelines 1
- Considered a secondary agent in the ACC/AHA hypertension guidelines 1
- Typical dosing range: 25-100 mg daily 1
For Resistant Hypertension
- Recommended as the fourth-line agent in patients with resistant hypertension after optimizing a three-drug regimen including a diuretic 1
- Most effective when added to patients whose serum potassium is <4.5 mmol/L and eGFR is >45 ml/min/1.73m² 1
- Provides significant additional blood pressure reduction (average 21-25/10-12 mmHg) when added to multidrug regimens 3, 4
- Superior to renal denervation for reducing 24-hour systolic and diastolic blood pressure in resistant hypertension 5
For Primary Aldosteronism
- Preferred agent for primary aldosteronism 1, 2
- Particularly effective in bilateral adrenal disease not amenable to surgery 1
- Effective in patients with resistant hypertension regardless of primary aldosteronism status 3
Dosing Considerations
- Starting dose: 25 mg daily 1, 2
- Low doses (12.5-25 mg) can be effective in resistant hypertension 3
- Can be titrated up to 50-100 mg daily if needed 2, 3
- Doses greater than 100 mg/day generally do not provide additional blood pressure reduction 2
Monitoring and Precautions
Regular monitoring required for:
- Serum potassium (risk of hyperkalemia)
- Renal function (can cause acute kidney injury)
- Side effects (gynecomastia, impotence in men)
Contraindications/Cautions:
Advantages Over Other Agents
- More effective than other fourth-line agents for resistant hypertension (demonstrated in PATHWAY-2 trial) 1
- Provides additional benefit even when combined with ACE inhibitors, ARBs, and diuretics 3
- Beneficial in patients with heart failure with reduced ejection fraction 2
- Effective in both African American and white patients with resistant hypertension 3
Alternative Options When Spironolactone is Not Tolerated
If spironolactone cannot be used due to side effects or contraindications, alternatives include:
- Eplerenone (less risk of hormonal side effects but less potent and requires twice-daily dosing) 1
- Amiloride 1, 6
- Other options: doxazosin, clonidine, or beta-blockers 1
Clinical Pearls
- Spironolactone's antihypertensive effect is often seen within 6 weeks of initiation 3
- The blood pressure-lowering effect persists at 6 months of follow-up 3
- Consider screening for primary aldosteronism in resistant hypertension before initiating spironolactone 1
- Newer non-steroidal MRAs (esaxerenone, finerenone) may offer alternatives with fewer side effects in the future 1
Spironolactone remains an underutilized but highly effective option for managing hypertension, particularly in the resistant hypertension setting where it should be considered before more invasive approaches 7, 5.